Skip to content
All guides
Guide

Nasal sprays

Why some peptides work nasally and most don’t, what to dilute with, and what each pump actually delivers.

Scope note. Most peptides in this library are dosed subcutaneously — none of the FDA-approved metabolic peptides (tirzepatide, semaglutide) or the GH-axis peptides we cover are available as nasal sprays. This guide is a general primer; nasal use of specific peptides varies wildly in evidence quality and is mostly community practice. Always discuss off-label routes with a clinician.

Why nasal at all

The nasal mucosa is thin, vascular, and sits right next to the brain. Two things follow:

  • Small molecules can absorb directly into the bloodstream without going through the gut or liver — this skips the first-pass metabolism that destroys most orally-taken peptides.
  • There’s a plausible direct nose-to-brain pathway via the olfactory nerve. For peptides targeting the central nervous system, this is theoretically attractive — though the clinical relevance is debated for most molecules.

The catch is molecular size. The nasal mucosa is permeable to small peptides; it’s a barrier to large ones. Bioavailability falls off sharply as molecules get bigger.

Which peptides are nasally absorbable

Generally suitable (small enough for meaningful nasal absorption)

  • Oxytocin (9 amino acids). Has an FDA-approved clinical IV form; nasal forms are studied for autism, social cognition, and pair-bonding contexts. Off-label community use is widespread.
  • Selank and Semax (Russian-origin nootropics, both ~7 amino acids). Specifically formulated as nasal sprays in their countries of origin. Not FDA-approved in the US.
  • DSIP (delta sleep-inducing peptide, 9 amino acids). Sometimes administered nasally in community protocols.
  • Insulin (51 amino acids, but on the borderline). Intranasal insulin is well-studied for cognitive applications.
  • Melanotan II (7 amino acids). Sometimes used nasally; off-label and unregulated.

Generally NOT suitable (too large or wrong target)

  • Tirzepatide (~39 amino acids), semaglutide (~31), tesamorelin (44), BPC-157 (15 — borderline but typically used SubQ), TB-500 (17 — same), most peptides over 30 amino acids.
  • Why: nasal bioavailability for these is poor (typically <5%) — you’d need 20+ pumps to approach a SubQ-equivalent dose, which is impractical, expensive, and irritating to the mucosa.
  • GHK-Cu, CJC-1295, ipamorelin — also typically not nasal. Topical (GHK-Cu) or SubQ (the others) is the studied route.

Rule of thumb: peptides under ~10 amino acids are nasal candidates; peptides over ~30 amino acids generally aren’t. The 10–30 range varies — depends on the specific molecule.

What to dilute with — saline, not BAC water

For nasal administration, the right vehicle is 0.9% sterile saline (sometimes called “normal saline”). Why:

  • Isotonic with nasal mucosa. 0.9% sodium chloride matches the salt concentration of nasal tissue. Hypotonic or hypertonic solutions sting and irritate.
  • pH-friendly. Most clinical saline is buffered to ~pH 6.5–7.0, which the nasal mucosa tolerates well.
  • BAC water (bacteriostatic water with 0.9% benzyl alcohol) is great for SubQ injection but more irritating intranasally. Some users tolerate it; some have chronic irritation. Saline is the safer default.
  • Pure sterile water is hypotonic — never use it as a final vehicle for nasal sprays. It will sting and cause mucosal damage with repeated use.

Practical option: preservative-free single-dose saline ampules (sold for contact lens solution and nasal irrigation). Open one ampule per reconstitution, dispose after.

What each pump delivers

Standard nasal spray pumps dispense ~0.1 mL (100 microliters) per actuation. This is true for most clinical and consumer nasal sprays. So:

  • Bottle volume: 5–15 mL is typical → 50–150 pumps per bottle.
  • Concentration math: if your bottle is 5 mL and you reconstituted 5 mg of peptide into it, that’s 1 mg/mL → 100 mcg per pump (0.1 mL × 1 mg/mL × 1000 mcg/mg).
  • Multi-pump dosing is common — “2 pumps per nostril, daily” would deliver 0.4 mL (4 × 0.1 mL). Verify the pump’s spec before assuming 0.1 mL.

Priming, technique, and rotation

  • Prime the pump on first use by spraying several pumps into a tissue until a fine mist comes out consistently. The first few pumps from a fresh bottle are typically air or partial liquid.
  • Tilt your head slightly forward, not back — this keeps the spray on the nasal mucosa rather than running down your throat (where it won’t absorb).
  • Sniff gently while pumping. Don’t inhale hard — that pulls the spray past the absorption zone.
  • Alternate nostrils across doses. Each nostril’s mucosa needs recovery time; chronic single-nostril dosing causes local irritation.
  • Don’t share bottles. Nasal pumps are single-user devices.

Storage of nasal-spray solutions

Once the peptide is in saline, the same shelf-life rules as any reconstituted peptide apply (see the storage guide): refrigerated, away from light, 4–6 weeks of efficacy. Saline-based formulations may degrade slightly faster than BAC-water formulations because there’s no bacteriostatic agent — though the saline itself is sterile to start.

What to discuss with your clinician

  • Whether the peptide you’re considering has any published evidence for nasal administration — for many it doesn’t.
  • Whether a clinical-grade compounding pharmacy can prepare the formulation properly — they have access to sterile fill equipment and pH-correct vehicles.
  • Whether nasal absorption variability matters for your goal (it often does — therapeutic-window peptides like insulin need predictable absorption).

Reminder: Juno is an educational reference. Nasal administration of peptides is a niche, mostly community-practice space — most of the information above is general principle plus published data on the few molecules with real nasal evidence. Talk to a qualified clinician before adopting a nasal protocol.